NCT06250244 2024-12-11
177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer
Peking Union Medical College Hospital
Phase 1/2 Unknown
Clinical Trials
1,039 trialsNCT06624813 2024-10-03
P-RALP
Instituto do Cancer do Estado de São Paulo
Phase NA Unknown
NCT05644821 2024-10-01
PRO-P
Heinrich-Heine University, Duesseldorf
Phase NA Unknown
NCT03362801 2024-07-19
SAMPHYR
University Hospital, Caen
Phase NA Unknown
NCT05155618 2024-06-18
MicroStyle
European Institute of Oncology
Phase NA Unknown
NCT05899751 2024-05-10
Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate
BTG International Inc.
Unknown
NCT06363123 2024-04-15
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
Unknown
NCT06347614 2024-04-04
Two-step RP
Sun Yat-sen University
Unknown
NCT06342323 2024-04-02
ONFM-SBRT
Peking University Third Hospital
Unknown
NCT06334406 2024-03-28
immunoBLAD
Centre Hospitalier Universitaire de Besancon
Unknown
NCT05115812 2024-03-27
Renal Autotransplantation; Case Series
Methodist Health System
Unknown
NCT04088968 2024-03-22
STRONG-CS
Bispebjerg Hospital
Phase NA Unknown
NCT01851018 2024-03-21
HyBraFi
CHU de Quebec-Universite Laval
Phase NA Unknown
NCT06322745 2024-03-21
Thulium Beam Coagulation Versus Suture Renorrhaphy for Hemostasis of Tumor Bed in Laparoscopic Partial Nephrectomy
Al-Azhar University
Phase NA Unknown
NCT06324058 2024-03-21
Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC
Huashan Hospital
Phase NA Unknown
NCT03795337 2024-03-20
HYPOSTAT-II
University Hospital Schleswig-Holstein
Phase NA Unknown
NCT06317948 2024-03-20
MIKAPOCo
IRCCS Ospedale San Raffaele
Unknown
NCT06321640 2024-03-20
POSITive
European Institute of Oncology
Unknown
NCT06317298 2024-03-19
Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy
Peking University First Hospital
Phase NA Unknown
NCT01802242 2024-03-18
Tumor TARGET Prostate Cancer
University Health Network, Toronto
Phase NA Unknown
NCT04997252 2024-03-18
An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate Cancer
Zhujiang Hospital
Phase NA Unknown
NCT05726136 2024-03-18
FC-VE
University Hospital, Linkoeping
Phase 4 Unknown
NCT05740488 2024-03-15
Efficacy and Safety of Apalutamide in Combination With 89Sr as Neoadjuvant Therapy in Prostate Cancer With ≤10 Bone Metastases
Zhujiang Hospital
Phase NA Unknown
NCT05671900 2024-03-08
Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer
Clinical Hospital Centre Zagreb
Phase NA Unknown
NCT06298305 2024-03-07
QUANTIB
IRCCS San Raffaele
Unknown
NCT03580109 2024-03-06
THERMOEDEME
Association Francaise pour la Recherche Thermale
Phase NA Unknown
NCT06294054 2024-03-06
SELECT
University Hospital, Rouen
Unknown
NCT05710159 2024-03-01
iBLAD-app
Odense University Hospital
Unknown
NCT06288802 2024-03-01
Study of Wilms Tumors Among Patients of Shefa Al-Orman Children Cancer Hospital
South Egypt Cancer Institute
Unknown
NCT05946161 2024-02-29
Testing an e-Health Intervention for Prostate Cancer Survivors' Mental and Sexual Health
Universidade do Porto
Phase NA Unknown
NCT04641078 2024-02-28
DART
University Hospital, Ghent
Phase 2 Unknown
NCT05627752 2024-02-28
Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage
Zhongnan Hospital
Phase 2/3 Unknown
NCT06032910 2024-02-28
Surgical Mesh in Radical Cystectomy to Prevent Parastomal Hernias
Charles University, Czech Republic
Phase NA Unknown
NCT06231329 2024-02-28
Role of Elastography in Diagnosis of Testicular Tumors
Assiut University
Unknown
NCT06274684 2024-02-28
Feasibility of Virtual Reality Assistance in Prostate Biopsy Under Local Anesthesia.
University Hospital, Geneva
Phase NA Unknown
NCT06282354 2024-02-28
Telemedicine for Postoperative Follow-up After Oncological Surgeries
Instituto do Cancer do Estado de São Paulo
Unknown
NCT06258486 2024-02-26
Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks
Kaiser Permanente
Phase 4 Unknown
NCT04567719 2024-02-23
Measuring Taste Perception During Chemotherapy for Muscle Invasive Bladder Cancer
University of Kansas Medical Center
Unknown
NCT05279287 2024-02-22
VAMIS
The Griffin Institute
Unknown
NCT02077335 2024-02-21
Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer
CSSS de Gatineau
Phase 2 Unknown
NCT06251492 2024-02-20
Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)
Fudan University
Phase 2 Unknown
NCT06253091 2024-02-20
Comparison of the Application of Robot-assisted Laparoscopic Pathways in Radical Cystectomy
The First Affiliated Hospital with Nanjing Medical University
Phase NA Unknown
NCT03924466 2024-02-16
VUBAR
Universitair Ziekenhuis Brussel
Phase 2 Unknown
NCT06148220 2024-02-16
A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors
Huashan Hospital
Phase NA Unknown
NCT05612204 2024-02-14
BIOPROSTATIRM
GCS Ramsay Santé pour l'Enseignement et la Recherche
Phase NA Unknown
NCT05626101 2024-02-13
Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
Al-Azhar University
Phase NA Unknown
NCT05829057 2024-02-13
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
Phase 1 Unknown
NCT03899077 2024-02-07
SAVE
Cancer Research Antwerp
Phase 2 Unknown
NCT04419402 2024-02-07
ENZA-p
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2 Unknown
NCT06245759 2024-02-07
The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients
Huazhong University of Science and Technology
Unknown